PT  - JOURNAL ARTICLE
AU  - Mah-Som, Annelise Y.
AU  - Daw, Jil
AU  - Huynh, Diana
AU  - Wu, Mengcheng
AU  - Creekmore, Benjamin C.
AU  - Burns, William
AU  - Skinner, Steven A.
AU  - Holla, Øystein L.
AU  - Smeland, Marie F.
AU  - Planes, Marc
AU  - Uguen, Kevin
AU  - Redon, Sylvia
AU  - Bierhals, Tatjana
AU  - Scholz, Tasja
AU  - Denecke, Jonas
AU  - Mensah, Martin A.
AU  - Sczakiel, Henrike L.
AU  - Tichy, Heidelis
AU  - Verheyen, Sarah
AU  - Blatterer, Jasmin
AU  - Schreiner, Elisabeth
AU  - Thies, Jenny
AU  - Lam, Christina
AU  - Spaeth, Christine
AU  - Pena, Loren
AU  - Ramsey, Keri
AU  - Narayanan, Vinodh
AU  - Seaver, Laurie H.
AU  - Rodriguez, Diana
AU  - Afenjar, Alexandra
AU  - Burglen, Lydie
AU  - Lee, Edward B.
AU  - Chou, Tsui-Fen
AU  - Weihl, Conrad C.
AU  - Shinawi, Marwan S.
TI  - A Novel Autosomal Dominant Childhood-Onset Disorder Associated with Pathogenic Variants in <em>VCP</em>
AID  - 10.1101/2023.06.19.23291232
DP  - 2023 Jan 01
TA  - medRxiv
PG  - 2023.06.19.23291232
4099  - http://medrxiv.org/content/early/2023/06/22/2023.06.19.23291232.short
4100  - http://medrxiv.org/content/early/2023/06/22/2023.06.19.23291232.full
AB  - Valosin-containing protein (VCP) is an AAA+ ATPase that plays critical roles in multiple ubiquitin-dependent cellular processes. Dominant pathogenic variants in VCP are associated with adult-onset multisystem proteinopathy (MSP) that presents with myopathy, bone disease, dementia, and/or motor neuron disease. Through GeneMatcher, we identified 13 unrelated individuals who carry novel heterozygous VCP variants (12 de novo, 1 inherited) associated with a childhood-onset disorder characterized by developmental delay, intellectual disability, hypotonia, and macrocephaly. Trio exome sequencing or multigene panel identified nine missense variants, two in-frame deletions, one frameshift, and one splicing variant. We performed in vitro functional studies and in silico modelling to investigate the impact of these variants on protein function. In contrast to MSP variants, most missense variants had decreased ATPase activity, and one caused hyperactivation. Other variants were predicted to cause haploinsufficiency, suggesting a loss-of-function mechanism. This is the first description of VCP-related neurodevelopmental disease presenting in childhood.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of Washington University in St. Louis gave ethical approval for this work. IRB of Seattle Children's Hospital gave ethical approval for this work. IRB of WCG gave ethical approval for this work (Protocol #20120789). IRB of Helen DeVos Children's Hospital waived ethical approval for this work. IRB of Hospital Trousseau gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesWe, or the sequencing laboratory, have submitted these variants and associated phenotypes to ClinVar. Anonymized data will be shared by request from any qualified investigator.